Skip to main content
. 2015 Feb 24;6(6):3553–3562. doi: 10.18632/oncotarget.3348

Figure 9. Graphene oxide (GO): Targeting cancer stem cells with differentiation-based nano-therapy.

Figure 9

Our current mechanistic studies suggest that GO could directly be used as a therapeutic for targeting CSCs, because of its ability to induce differentiation. In this context, we might envision that GO could used to clear residual CSCs, with the aim of preventing tumor recurrence and distant metastasis, thereby providing a practical means for achieving “differentiation-based nano-therapy”.